Healthcare Regulation and Compliance in the GCC

The healthcare sector in the Gulf Cooperation Council (GCC) region is undergoing rapid transformation, driven by population growth, increasing prevalence of lifestyle diseases, ambitious national health strategies, and significant public and private investment. Each GCC member state has established a comprehensive healthcare regulatory framework covering licensing of healthcare professionals and facilities, quality standards, patient safety, data protection, pharmaceuticals, and medical devices. Navigating this multi-jurisdictional regulatory landscape is essential for healthcare providers, pharmaceutical companies, medical device manufacturers, and health insurers operating in the region. This guide provides a detailed analysis of healthcare regulation across all six GCC countries.

Published: 25 July 2026 | Last updated: 25 July 2026 | Author: Mustafa Hasan, Lead Auditor | Reviewed by: Bitrixme Compliance Team

Key Takeaways

• Each GCC country operates distinct healthcare regulatory bodies: NHRA (Bahrain), CBAHI (Saudi Arabia), DHA/HAAD/DOH (UAE), MOPH (Qatar), MOH (Kuwait), and MOH (Oman), each with unique licensing and quality frameworks.
• Healthcare facility licensing requirements vary significantly across jurisdictions, with mandatory accreditation increasingly tied to operating licences.
• Patient safety standards are enforced through national quality frameworks, with Saudi Arabia’s CBAHI and the UAE’s DHA leading regional quality improvement initiatives.
• Health data protection laws impose strict requirements on the collection, storage, and sharing of patient information, with sector-specific regulations in the UAE and Saudi Arabia.
• Pharmaceutical and medical device regulation follows international standards (ICH, ISO 13485) with national registration requirements for all products marketed in each jurisdiction.

Healthcare Regulatory Authorities by Country

The GCC healthcare regulatory landscape is characterised by a mix of national ministries, independent regulatory authorities, and regional health authorities. The following table provides a comparative overview of the principal regulators in each jurisdiction:

Bahrain: National Health Regulatory Authority (NHRA)

Bahrain’s healthcare sector is regulated by the National Health Regulatory Authority (NHRA), established under Health Law No. 18 of 2015. The NHRA operates independently of the Ministry of Health and is responsible for licensing healthcare facilities and professionals, setting quality standards, and enforcing compliance. Bahrain also has the Supreme Council of Health (SCH), which sets health policy and strategy.

Licensing of Healthcare Facilities

All healthcare facilities in Bahrain must obtain a licence from the NHRA. The licensing process includes a review of facility design, equipment, staffing, and policies. Facilities must renew their licences annually and are subject to inspection by NHRA inspectors. The NHRA classifies facilities by type (hospital, polyclinic, clinic, diagnostic centre, pharmacy, etc.) and applies specific requirements to each category.

Professional Licensing

Healthcare professionals must register with the NHRA before practising in Bahrain. Requirements include verification of qualifications from recognised institutions, minimum experience criteria, and passing a licensing examination where required. The NHRA maintains a public register of licensed professionals. Continuing professional development (CPD) is mandatory for licence renewal.

Saudi Arabia: CBAHI and SFDA Regulation

Saudi Arabia has the largest and most complex healthcare regulatory environment in the GCC, with multiple authorities responsible for different aspects of healthcare regulation. The Ministry of Health (MOH) is the principal health authority, while the Saudi Central Board for Accreditation of Healthcare Institutions (CBAHI) sets and enforces quality standards, and the Saudi Food and Drug Authority (SFDA) regulates pharmaceuticals and medical devices. The Health Holding Companies (HHCs) oversee the operational management of public hospitals under the Health Sector Transformation Programme.

CBAHI Accreditation

CBAHI accreditation is mandatory for all public and private healthcare facilities in Saudi Arabia. The CBAHI National Standards cover patient safety, clinical governance, infection control, medication management, facility management, and human resources. Facilities undergo a rigorous survey process every three years, with annual interim self-assessments. CBAHI standards align with international accreditation bodies including JCI and ISQua.

SFDA Pharmaceutical Regulation

The SFDA regulates the registration, manufacturing, import, distribution, and dispensing of pharmaceutical products in Saudi Arabia. All pharmaceutical products must be registered with the SFDA before marketing. The SFDA requires good manufacturing practice (GMP) certification for manufacturing facilities, good distribution practice (GDP) for wholesalers, and pharmacovigilance systems for post-market surveillance. The SFDA has also implemented the Saudi Drug Code (SDC) for traceability.

United Arab Emirates: DHA, DOH, and MOHAP

The UAE has a unique multi-regulator healthcare system reflecting its federal structure. Healthcare in Dubai is regulated by the Dubai Health Authority (DHA), in Abu Dhabi by the Department of Health (DOH), and in the Northern Emirates by the Ministry of Health and Prevention (MOHAP). Each regulator has its own licensing framework, quality standards, and enforcement mechanisms.

Dubai Health Authority (DHA) Regulation

The DHA regulates all healthcare facilities and professionals in Dubai’s mainland (excluding the Dubai Healthcare City free zone, which has its own regulator). The DHA operates the NABIDH (National Unified Medical Record) platform for health data exchange and has implemented a comprehensive Health Regulation Framework covering licensing, quality, and patient safety. The DHA also sets health insurance standards through its Health Funding Department.

Abu Dhabi Department of Health (DOH) Regulation

The DOH (formerly HAAD) is responsible for healthcare regulation in the Emirate of Abu Dhabi. The DOH operates the Malaffi health information exchange platform and has developed the comprehensive DOH Healthcare Standards covering quality, patient safety, infection control, and clinical governance. Abu Dhabi was the first emirate to mandate mandatory health insurance for all residents, a model later adopted in Dubai. The DOH also operates the Jaheziya readiness programme for emergency preparedness.

Qatar: Ministry of Public Health (MOPH)

Qatar’s healthcare sector is regulated by the Ministry of Public Health (MOPH), which sets health policy, licenses healthcare facilities and professionals, and oversees quality and patient safety. The MOPH works alongside the Qatar Council for Healthcare Practitioners (QCHP), which handles professional licensing and registration.

Qatar National Health Strategy

The Qatar National Health Strategy 2018-2022 (and its successor) establishes the framework for healthcare development in Qatar. The strategy focuses on improving population health outcomes, enhancing patient experience, and achieving value-based care. Key regulatory initiatives include the implementation of mandatory accreditation for all healthcare facilities, the expansion of the Al Naeem health insurance programme, and the development of the Qatar Health Information Exchange (HIE) platform.

Professional Licensing by QCHP

The Qatar Council for Healthcare Practitioners (QCHP) is responsible for the registration and licensing of all healthcare professionals in Qatar. Practitioners must hold recognised qualifications, pass a QCHP licensing examination (where applicable), and demonstrate language proficiency in English or Arabic. The QCHP requires all licensed professionals to complete mandatory CPD hours annually for licence renewal.

Patient Safety and Quality Standards

Patient safety is a regulatory priority across all GCC jurisdictions. Each country has established national quality standards and patient safety frameworks, often aligned with international standards such as those of the Joint Commission International (JCI) and the International Society for Quality in Healthcare (ISQua).

Health Data Protection

Health data is subject to additional protection beyond general data protection laws in most GCC jurisdictions. The sensitivity of health information and the increasing digitisation of healthcare records have prompted regulators to introduce specific health data protection requirements.

UAE Health Data Law

The UAE has specific health data protection regulations. The DHA’s Health Data Law and the DOH’s health information privacy regulations impose strict requirements on the collection, storage, and sharing of patient data. The DHA’s NABIDH platform requires all Dubai healthcare facilities to submit patient data to a central repository, with strict access controls and audit trails. The DOH’s Malaffi system operates similarly in Abu Dhabi. Penalties for breaching health data confidentiality can reach AED 500,000.

Saudi Health Data Requirements

Saudi Arabia’s Health Information Exchange (HIE) regulations under the National Health Information Centre (NHIC) require healthcare providers to share patient data through the unified HIE platform. The Saudi PDPL applies to health data as sensitive personal data, requiring explicit consent for processing and strict data localisation. The SFDA also regulates health data related to clinical trials and pharmacovigilance.

Pharmaceutical and Medical Device Regulation

Pharmaceutical and medical device regulation in the GCC follows international standards while maintaining national registration requirements. Each jurisdiction requires product registration before marketing, GMP compliance for manufacturing, and pharmacovigilance systems for post-market surveillance.

Drug Registration and Pricing

Pharmaceutical products must be registered in each GCC country where they are marketed. The Saudi SFDA, UAE MOHAP, and other national authorities evaluate product safety, efficacy, and quality before granting marketing authorisation. Several GCC countries participate in the GCC Drug Registration System, which provides a centralised registration process through the Executive Office of the GCC Health Ministers’ Council. However, full harmonisation has not been achieved, and some countries require separate national registration.

Medical Devices

Medical device regulation varies significantly. The UAE’s MOHAP regulates medical devices under the UAE Medical Device Regulations (Cabinet Resolution No. 57/2020). The SFDA in Saudi Arabia has implemented a comprehensive medical device regulatory framework requiring registration, quality management system certification (ISO 13485), and conformity assessment. Bahrain’s NHRA and Qatar’s MOPH have also introduced medical device registration requirements, while Kuwait and Oman are in the process of strengthening their medical device regulatory frameworks.

Accreditation and International Standards

International accreditation is highly valued across the GCC healthcare sector. Many leading hospitals pursue Joint Commission International (JCI) accreditation alongside national accreditation. JCI accreditation is particularly sought after by private hospitals targeting medical tourism and by government hospitals seeking international benchmarking. Canada’s Accreditation Canada International (ACI), the Australian Council on Healthcare Standards (ACHS), and ISO 9001 certification are also recognised across the region.

National accreditation is increasingly tied to operating licences. Saudi Arabia mandates CBAHI accreditation for all facilities. The UAE’s DHA and DOH require facilities to achieve national accreditation standards. Bahrain’s NHRA has developed mandatory quality standards that function as a de facto accreditation system. Qatar links facility licensing to MOPH quality standards compliance. Kuwait and Oman are progressively moving towards mandatory accreditation frameworks.

Frequently Asked Questions

Do healthcare professionals need separate licences for each GCC country?

Yes. There is no automatic mutual recognition of healthcare professional licences across GCC countries. Professionals must obtain a licence from the relevant regulatory authority in each jurisdiction where they wish to practise. However, some progress has been made toward mutual recognition of qualifications under the GCC Health Ministers’ Council.

What is CBAHI and is it mandatory in Saudi Arabia?

CBAHI (Saudi Central Board for Accreditation of Healthcare Institutions) is the national accreditation body for healthcare facilities in Saudi Arabia. CBAHI accreditation is mandatory for all public and private hospitals, polyclinics, and other healthcare facilities operating in the Kingdom.

How does medical device registration work in the GCC?

Medical devices must be registered in each country where they are marketed. The SFDA (Saudi Arabia) and MOHAP (UAE) have the most developed registration frameworks. Other GCC countries require registration with varying levels of stringency. ISO 13485 certification is typically required as part of the registration process.

Are there specific health data protection laws beyond general data protection?

Yes. The UAE has specific health data regulations from DHA and DOH. Saudi Arabia treats health data as sensitive personal data under its PDPL and has additional NHIC/HIE regulations. Qatar, Kuwait, Bahrain, and Oman apply general data protection laws to health data, with additional sector-specific guidance from health authorities.

What is the role of the GCC Health Ministers’ Council?

The GCC Health Ministers’ Council coordinates health policy across GCC member states, promotes harmonisation of pharmaceutical registration, facilitates mutual recognition of professional qualifications, and manages joint health initiatives such as the GCC Drug Registration System and the GCC Health Information Exchange project.

How Bitrixme Can Help

Bitrixme provides comprehensive healthcare compliance services across the GCC, including healthcare facility licensing support, professional registration assistance, quality management system development, CBAHI readiness assessments, JCI accreditation preparation, health data protection compliance, pharmaceutical and medical device registration, and compliance auditing. Our team includes experienced healthcare quality professionals and regulatory specialists across all GCC jurisdictions. Contact Bitrixme today for a compliance assessment or reach out on WhatsApp for an immediate consultation.

Disclaimer: This article provides general guidance on GCC healthcare regulation and does not constitute legal or regulatory advice. Organisations should consult qualified healthcare regulatory professionals for advice specific to their circumstances and jurisdictions of operation.